eli lilly glp-1 mounjaro endowment Diabetes Patients Also Struggle to Access Agonists Lilly is selling $12.9 billion

The researchers found that patients who gained or maintained weight while on a GLP-1 receptor agonist were more likely to lose weight after switching to phentermine, with a median weight loss of around 3% in the year after GLP-1 discontinuation

Even with the familiar telehealth companies out there, you should still proceed with caution

Patients should discuss treatment duration expectations with their prescriber

Competitor platforms like Ro and Shed provide telehealth access to GLP-1 prescriptions, but the structure and frequency of follow-up monitoring may vary by provider and plan

Nearly a tenth of people will meet the clinical benchmarks of an eating disorder at some point in their lives

Lancet 2009;374(9701):160616